77 research outputs found

    Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development

    Get PDF
    Background: Coronaviruses pose a serious threat to global health as evidenced by Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and COVID-19. SARS Coronavirus (SARS-CoV), MERS Coronavirus (MERS-CoV), and the novel coronavirus, previously dubbed 2019-nCoV, and now officially named SARS-CoV-2, are the causative agents of the SARS, MERS, and COVID-19 disease outbreaks, respectively. Safe vaccines that rapidly induce potent and long-lasting virus-specific immune responses against these infectious agents are urgently needed

    Germany’s way from conventional power grids towards smart grids

    Full text link

    Safety Meetings Worth Having

    No full text

    Investing in Training

    No full text

    Understanding What Went Wrong

    No full text

    Measuring Safety Performance

    No full text

    Execution: The Name of the Game … and Safety's Bottom Line

    No full text
    corecore